Smolkina Olga Yurievna Smolkina Olga Yurievna Smolkina Olga Yurievna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Smolkina Olga Yurievna Smolkina Olga Yurievna Smolkina Olga Yurievna has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Irina Markovna Korsunskaya
Center for Theoretical Problems of Physicochemical Pharmacology, Institution of Russian Academy of Sciences
6 shared publications - Luiza R. Sakaniya
Center for Theoretical Problems of Physico-chemical Pharmacology of the Russian Academy of Sciences
3 shared publications - Sergey Sergeevich Masalskiy
Moscow medical university “REAVIZ
2 shared publications - Smolkin Yuri Solomonovich Smolkin Yuri Solomonovich Smolkin Yuri Solomonovich
Academy of Postgraduate Education under FSBI FSCC of FMBA of Russia; State Budgetary Healthcare Institution of the Moscow Region “Research and Clinical Institute of Childhood of the Ministry of Health of the Moscow Region
2 shared publications - Anastas L. Piruzyan
Center for Theoretical Problems of Physicochemical Pharmacology
1 shared publication - Elena V. Denisova
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology; Center for Theoretical Problems of Physical and Chemical Pharmacology of Russian Academy of Sciences
1 shared publication
Latest Publications
- Open Access
- 8 June 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 1,p. 25-29
Atopic dermatitis: the role of care products in common dermatosis in pediatric practice
Обоснование. Atopic dermatitis (AD) is one of the most common skin disorders in pediatric practice. In AD, the barrier function of the skin and moisturizing factors are impaired, which requires using specialized care products. Therefore, healthcare professionals should be aware of effective and safe products that can be used in children. Aim. To evaluate the clinical efficacy of LA-KRY cosmetics. Materials and methods. The study included 39 patients with AD and 26 patients with allergic/contact dermatitis aged 0-7 years. In some children, skin corneometric indices (SCI) (humidity and oiliness) were measured before using care products and 14 and 30 days after the start of their use to assess their effectiveness. In the remaining patients, the clinical manifestations of skin disorders were assessed visually without instrumental methods. Results. SCI improvement was observed after 14 days of using LA-KRY products and significantly improved by the end of month 1. Minimization of dryness and itching of the skin occurred by days 3-5, and clinical manifestations resolved by days 14-30 (depending on the nosology). Conclusion. LA-KRY have shown their effectiveness in children with several dermatoses associated with skin barrier disruption, dryness, and itching; in particular, they help reduce inflammation and discomfort and normalize SCI.
- 8 June 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 1,p. 25-29
Open AccessAtopic dermatitis: the role of care products in common dermatosis in pediatric practice
Обоснование. Atopic dermatitis (AD) is one of the most common skin disorders in pediatric practice. In AD, the barrier function of the skin and moisturizing factors are impaired, which requires using specialized care products. Therefore, healthcare professionals should be aware of effective and safe products that can be used in children. Aim. To evaluate the clinical efficacy of LA-KRY cosmetics. Materials and methods. The study included 39 patients with AD and 26 patients with allergic/contact dermatitis aged 0-7 years. In some children, skin corneometric indices (SCI) (humidity and oiliness) were measured before using care products and 14 and 30 days after the start of their use to assess their effectiveness. In the remaining patients, the clinical manifestations of skin disorders were assessed visually without instrumental methods. Results. SCI improvement was observed after 14 days of using LA-KRY products and significantly improved by the end of month 1. Minimization of dryness and itching of the skin occurred by days 3-5, and clinical manifestations resolved by days 14-30 (depending on the nosology). Conclusion. LA-KRY have shown their effectiveness in children with several dermatoses associated with skin barrier disruption, dryness, and itching; in particular, they help reduce inflammation and discomfort and normalize SCI.
- 22 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 23 (6)
Correction of seasonal skin problems
Human skin performs many functions, including protection of the body from external factors and irritants. These factors affect the skin’s characteristics, in particular its response to changes in temperature and humidity of the air. Studies on the effect of conditions with low relative air humidity on skin are limited. They show that such conditions adversely affect the skin, transepidermal water loss enhances, risk of developing allergic reactions increases. Most often such negative influence was studied in persons with existing dermatological conditions. Nevertheless, characteristics of healthy skin deteriorate under adverse external conditions as well, it is observed especially often in winter, from exposure not only to cold air on the street, but also to dry indoor air. It has been shown that a 6-hour stay in winter in the dry office causes an increase of skin temperature, redness, enhances skin microrelief intensity and transepidermal water loss. These effects lead to skin barrier disruption, but as some studies show, lipid-replenishing skincare products can improve the skin barrier function that is affected by adverse climatic factors. The replacement of lipids deficiency will contribute to the restoration of skin barrier considering that stratum corneum is mainly consisted of lipid structures. In particular, products containing such components as fatty acids (oleic, linoleic and etc.) and softening agents may be used to eliminate unpleasant sensations and symptoms caused by dry and/or cool air, low temperatures and other adverse climatic factors.
- 22 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 23 (6)
Correction of seasonal skin problems
Human skin performs many functions, including protection of the body from external factors and irritants. These factors affect the skin’s characteristics, in particular its response to changes in temperature and humidity of the air. Studies on the effect of conditions with low relative air humidity on skin are limited. They show that such conditions adversely affect the skin, transepidermal water loss enhances, risk of developing allergic reactions increases. Most often such negative influence was studied in persons with existing dermatological conditions. Nevertheless, characteristics of healthy skin deteriorate under adverse external conditions as well, it is observed especially often in winter, from exposure not only to cold air on the street, but also to dry indoor air. It has been shown that a 6-hour stay in winter in the dry office causes an increase of skin temperature, redness, enhances skin microrelief intensity and transepidermal water loss. These effects lead to skin barrier disruption, but as some studies show, lipid-replenishing skincare products can improve the skin barrier function that is affected by adverse climatic factors. The replacement of lipids deficiency will contribute to the restoration of skin barrier considering that stratum corneum is mainly consisted of lipid structures. In particular, products containing such components as fatty acids (oleic, linoleic and etc.) and softening agents may be used to eliminate unpleasant sensations and symptoms caused by dry and/or cool air, low temperatures and other adverse climatic factors.
- 22 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 23 (5)
Xerosis as the basis of dermatoses in an elderly age
Interest in geriatrics, including dermatological practice, is growing along with the increase in life expectancy. Therapy selection shall consider possible concomitant diseases and various skin changes associated with aging. During aging, the skin loses its strength and elasticity through degradation of collagen fibers. Structural and functional changes in the epidermis and dermis lead to a decrease in lipid and moisture content, manifested by xerosis, and is accompanied by itching. Older people often suffer from itching, which can occur due to xerosis and accompany several somatic pathologies. Age-related skin changes elevate the risk for the development of certain dermatoses. Older people often suffer from eczema of varied etiology, including nummular eczema. This group of patients is also susceptible to allergic dermatitis due to increased skin barrier permeability. Age-related immune system changes can, at times, cause atopic dermatitis. Moisturizers are indicated in all these conditions. Chronic inflammatory dermatoses can also impact aging-related diseases, like obesity, diabetes mellitus, cardiovascular diseases, and dementia. There is evidence that treating skin inflammation improves the course of these comorbidities. This data and the positive effect of moisturizers on older people’s quality of life highlight the importance of adequate skin hydration at that age, regardless of dermatological pathology.
- 22 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 23 (5)
Xerosis as the basis of dermatoses in an elderly age
Interest in geriatrics, including dermatological practice, is growing along with the increase in life expectancy. Therapy selection shall consider possible concomitant diseases and various skin changes associated with aging. During aging, the skin loses its strength and elasticity through degradation of collagen fibers. Structural and functional changes in the epidermis and dermis lead to a decrease in lipid and moisture content, manifested by xerosis, and is accompanied by itching. Older people often suffer from itching, which can occur due to xerosis and accompany several somatic pathologies. Age-related skin changes elevate the risk for the development of certain dermatoses. Older people often suffer from eczema of varied etiology, including nummular eczema. This group of patients is also susceptible to allergic dermatitis due to increased skin barrier permeability. Age-related immune system changes can, at times, cause atopic dermatitis. Moisturizers are indicated in all these conditions. Chronic inflammatory dermatoses can also impact aging-related diseases, like obesity, diabetes mellitus, cardiovascular diseases, and dementia. There is evidence that treating skin inflammation improves the course of these comorbidities. This data and the positive effect of moisturizers on older people’s quality of life highlight the importance of adequate skin hydration at that age, regardless of dermatological pathology.
- Open Access
- 27 July 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 12,p. 151-155
A challenge in paediatrics: concurrent atopic dermatitis and vitiligo
Atopic dermatitis is one of the most common dermatoses globally. It has been established that it can often be associated with a variety of autoimmune diseases. Vitiligo is one of such comorbidities. This concurrent combination is most often found in paediatric practice, as an early onset is typical for both diseases. Early onset of vitiligo and involvement of a larger area of skin have been shown to be associated with higher odds of atopic dermatitis. The pathogenesis of vitiligo is characterized by altered immune responses, and genetic factors also counts. It has been shown that some of these mechanisms are shared with the pathogenesis of atopic dermatitis, but the issue warrants further study. Oxidative stress triggering melanocytes destruction is believed to be a key factor in the development of vitiligo. In this regard, patients with vitiligo are advised to use photoprotective agents. Today, the study of effects of visible light on the skin is a very topical issue, specifically, particular attention is paid to blue light (400-500 nm). Studies show that it is this wavelength that has a more pronounced negative effect on the skin. However, research findings are contradictory, as this spectrum radiation is used in the treatment of various dermatoses, including atopic dermatitis. Thus, the concurrent vitiligo and atopic dermatitis place certain restrictions on the choice of therapy, care products and photoprotective agents. A photoprotective agent for such difficult patients should protect the skin from exposure to as wide solar radiation spectrum as possible and at the same time not contain potentially allergenic components that can aggravate the course of atopic dermatitis.
- 27 July 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 12,p. 151-155
Open AccessA challenge in paediatrics: concurrent atopic dermatitis and vitiligo
Atopic dermatitis is one of the most common dermatoses globally. It has been established that it can often be associated with a variety of autoimmune diseases. Vitiligo is one of such comorbidities. This concurrent combination is most often found in paediatric practice, as an early onset is typical for both diseases. Early onset of vitiligo and involvement of a larger area of skin have been shown to be associated with higher odds of atopic dermatitis. The pathogenesis of vitiligo is characterized by altered immune responses, and genetic factors also counts. It has been shown that some of these mechanisms are shared with the pathogenesis of atopic dermatitis, but the issue warrants further study. Oxidative stress triggering melanocytes destruction is believed to be a key factor in the development of vitiligo. In this regard, patients with vitiligo are advised to use photoprotective agents. Today, the study of effects of visible light on the skin is a very topical issue, specifically, particular attention is paid to blue light (400-500 nm). Studies show that it is this wavelength that has a more pronounced negative effect on the skin. However, research findings are contradictory, as this spectrum radiation is used in the treatment of various dermatoses, including atopic dermatitis. Thus, the concurrent vitiligo and atopic dermatitis place certain restrictions on the choice of therapy, care products and photoprotective agents. A photoprotective agent for such difficult patients should protect the skin from exposure to as wide solar radiation spectrum as possible and at the same time not contain potentially allergenic components that can aggravate the course of atopic dermatitis.
- Open Access
- 17 July 2023
- Published by Association of Pediatric Allergologists and Immunologists of Russia in Allergology and Immunology in Paediatrics
- No. 2,p. 16-32
Clinical and hardware evaluation of moisturizing properties and tolerability of a emollient cream with filagrinol (“Admera”) in atopic dermatitis in children
Objective. Evaluate the possibility of using a cream with 5 % filagrinol ("Admera") in children (0-18 years old) as an emollient in atopic dermatitis (AtD) and receive hardware measurements of skin hydration.Materials and methods. Open interventional study in parallel groups of children with AtD 0-18 years old (n = 72, median age 6 [3.75; 7.0] years). 2 equal groups: group 1 received methylprednisolone cream 1 time daily on lesions for 14 days + Admera emollient on the other skin; group 2 received the same treatment + cream with filagrinol 5 % applied from day 5 on the lesions.Results. Standard therapy with topical steroids and emollients was effective. The severity indices during steroid + emollient treatment decreased significantly: EASI 11.5 [6.0; 17.0] vs 2 [1; 3.8] scores, p < 0.001; skin lesion area from 17.5 % [10.0; 26.8 %] to 3.5 % [1.25; 6.0 %], p < 0.001; IGA score — 2 [2; 3] vs 1 [1; 2], p < 0.01.The total itching score for AtD (max 10) became significantly lower with therapy: nocturnal itching decreased from 3 [1; 7] to 1 [1; 3] and daytime itching from 4 [3; 7] to 2.5 [1; 4] points, p < 0.01.The mean values of hardware-measured skin hydration outside the lesion areas were 8 [6.0; 12.0] units at baseline. After 14 days of emollient, hydration of dry clear skin increased to 10 [8.0; 15.0] units (p = 0,017). The hydration of the skin on the affected areas increased significantly from 8 [6; 10] to 12.0 [8; 15] units (p = 0.001).The patients' organoleptic evaluation of the cream was 4.48 (max 5). No serious or moderate adverse events (AEs) were reported in this study. In 11.3 % of cases, the skin itching was detected, but resolved rapidly without treatment.Conclusion. The cream with 5 % filagrinol (“Admera”) significantly improved skin hydration, as measured instrumentally, in the area of dermatitis and dry skin without ones. The cream caused no significant adverse reactions and could be used together with topical steroids.
- 17 July 2023
- Published by Association of Pediatric Allergologists and Immunologists of Russia in Allergology and Immunology in Paediatrics
- No. 2,p. 16-32
Open AccessClinical and hardware evaluation of moisturizing properties and tolerability of a emollient cream with filagrinol (“Admera”) in atopic dermatitis in children
Objective. Evaluate the possibility of using a cream with 5 % filagrinol ("Admera") in children (0-18 years old) as an emollient in atopic dermatitis (AtD) and receive hardware measurements of skin hydration.Materials and methods. Open interventional study in parallel groups of children with AtD 0-18 years old (n = 72, median age 6 [3.75; 7.0] years). 2 equal groups: group 1 received methylprednisolone cream 1 time daily on lesions for 14 days + Admera emollient on the other skin; group 2 received the same treatment + cream with filagrinol 5 % applied from day 5 on the lesions.Results. Standard therapy with topical steroids and emollients was effective. The severity indices during steroid + emollient treatment decreased significantly: EASI 11.5 [6.0; 17.0] vs 2 [1; 3.8] scores, p < 0.001; skin lesion area from 17.5 % [10.0; 26.8 %] to 3.5 % [1.25; 6.0 %], p < 0.001; IGA score — 2 [2; 3] vs 1 [1; 2], p < 0.01.The total itching score for AtD (max 10) became significantly lower with therapy: nocturnal itching decreased from 3 [1; 7] to 1 [1; 3] and daytime itching from 4 [3; 7] to 2.5 [1; 4] points, p < 0.01.The mean values of hardware-measured skin hydration outside the lesion areas were 8 [6.0; 12.0] units at baseline. After 14 days of emollient, hydration of dry clear skin increased to 10 [8.0; 15.0] units (p = 0,017). The hydration of the skin on the affected areas increased significantly from 8 [6; 10] to 12.0 [8; 15] units (p = 0.001).The patients' organoleptic evaluation of the cream was 4.48 (max 5). No serious or moderate adverse events (AEs) were reported in this study. In 11.3 % of cases, the skin itching was detected, but resolved rapidly without treatment.Conclusion. The cream with 5 % filagrinol (“Admera”) significantly improved skin hydration, as measured instrumentally, in the area of dermatitis and dry skin without ones. The cream caused no significant adverse reactions and could be used together with topical steroids.
- Open Access
- 20 September 2022
- Published by Association of Pediatric Allergologists and Immunologists of Russia in Allergology and Immunology in Paediatrics
- No. 3
Clinical case of early debut of food allergy in a child up to 6 months
Introduction: It is believed that if the child ate only a cow’s milk formula (CMF), and сow's milk allergy is the only possible at the age of <6 months. This approach leads to erroneous treatment tactics. Presentation of the clinical case: a child aged 3 months with the debut of atopic dermatitis (AtD) of light degree (on the scale of the assessment of the researcher IGA 2). The patient was fed on artificial with a CMF from 1,5 months. Infant was examined at the place of residence. The CMF was changed to full hydrolysis CMF and without examination. Additionally, cosmetics were applied to the skin as needed. The child was examined by an allergologist after 3-4 weeks of diet. Negative dynamics were observed. Atopic dermatitis has become moderately severe with secondary infection complications (IGA 3, 50% affected skin). Prick-tests with allergens of milk, eggs, wheat, fish were carried out. High sensitization to egg and controversial to cow’s milk was found. The results were clarified during enzyme immunoassay: IgE ovomucoid – 0.78 IU/ml (norm <0.3 IU/ml); cow's milk 0.01 kUA/ l; casein – 0.01 kUA / l (norm <0.1 kUA/l). Considering the infected AtD, "hydrocortisone + natamycin + neomycin" 2 times a day was used in the therapy. Cosmetics on infected foci was canceled, while maintaining the treatment of dry unaffected skin. It is recommended to limit household contacts with eggs. After 2 weeks, the rash is residual (IGA 0-1). The cow’s milk formula was returned to the diet without exacerbations of the skin process. Conclusion: The case illustrates that sensitization in children can begin and be maintained without oral ingestion of the allergen. Sensitization at the age of up to 6 months is likely with a moderate – severe recurrent course of dermatitis. A specific allergological examination can be conduct with a developed disease at an early age. Skin tests and enzyme immunoassay are applicable in infants. The appointment of a diet without examination is unreasonable and should not be used.
- 20 September 2022
- Published by Association of Pediatric Allergologists and Immunologists of Russia in Allergology and Immunology in Paediatrics
- No. 3
Open AccessClinical case of early debut of food allergy in a child up to 6 months
Introduction: It is believed that if the child ate only a cow’s milk formula (CMF), and сow's milk allergy is the only possible at the age of <6 months. This approach leads to erroneous treatment tactics. Presentation of the clinical case: a child aged 3 months with the debut of atopic dermatitis (AtD) of light degree (on the scale of the assessment of the researcher IGA 2). The patient was fed on artificial with a CMF from 1,5 months. Infant was examined at the place of residence. The CMF was changed to full hydrolysis CMF and without examination. Additionally, cosmetics were applied to the skin as needed. The child was examined by an allergologist after 3-4 weeks of diet. Negative dynamics were observed. Atopic dermatitis has become moderately severe with secondary infection complications (IGA 3, 50% affected skin). Prick-tests with allergens of milk, eggs, wheat, fish were carried out. High sensitization to egg and controversial to cow’s milk was found. The results were clarified during enzyme immunoassay: IgE ovomucoid – 0.78 IU/ml (norm <0.3 IU/ml); cow's milk 0.01 kUA/ l; casein – 0.01 kUA / l (norm <0.1 kUA/l). Considering the infected AtD, "hydrocortisone + natamycin + neomycin" 2 times a day was used in the therapy. Cosmetics on infected foci was canceled, while maintaining the treatment of dry unaffected skin. It is recommended to limit household contacts with eggs. After 2 weeks, the rash is residual (IGA 0-1). The cow’s milk formula was returned to the diet without exacerbations of the skin process. Conclusion: The case illustrates that sensitization in children can begin and be maintained without oral ingestion of the allergen. Sensitization at the age of up to 6 months is likely with a moderate – severe recurrent course of dermatitis. A specific allergological examination can be conduct with a developed disease at an early age. Skin tests and enzyme immunoassay are applicable in infants. The appointment of a diet without examination is unreasonable and should not be used.
- Open Access
- 11 March 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 3,p. 32-36-36
Hand eczema: possible risks and choice of therapy
Hand eczema is a common disease – up to 5% in the general population. In addition, eczema is closely related to atopy and, like atopic dermatitis, to a mutation in the FLG gene. In addition to genetic factors, eczema is caused by external irritants and toxic substances. Eczema often occurs in families with atopic diseases, including asthma, allergic rhinitis/hay fever (and food allergies), and atopic dermatitis. These diseases share a common pathogenesis and often occur together in the same person and/or family. Eczematous rashes are often accompanied by itching. This symptom can lead not only to sleep disturbances but also to secondary infections. According to some data, the rate of infections in eczema can be more than 70%. In such cases, the drugs of choice are combined glucocorticosteroids (GC), which in addition to GC contain an antimycotic and an antibiotic. Our practical experience shows the high effectiveness of the combination of beclomethasone dipropionate, gentamicin, and clotrimazole not only in cases of eczema complicated by secondary infection but also in patients with other infected chronic dermatoses. This article reviews these and other practical aspects and problems in the treatment of hand eczema, discusses the etiological factors that lead to the development of the disease, and presents current data from clinical recommendations and guidelines for the treatment of eczema.
- 11 March 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 3,p. 32-36-36
Open AccessHand eczema: possible risks and choice of therapy
Hand eczema is a common disease – up to 5% in the general population. In addition, eczema is closely related to atopy and, like atopic dermatitis, to a mutation in the FLG gene. In addition to genetic factors, eczema is caused by external irritants and toxic substances. Eczema often occurs in families with atopic diseases, including asthma, allergic rhinitis/hay fever (and food allergies), and atopic dermatitis. These diseases share a common pathogenesis and often occur together in the same person and/or family. Eczematous rashes are often accompanied by itching. This symptom can lead not only to sleep disturbances but also to secondary infections. According to some data, the rate of infections in eczema can be more than 70%. In such cases, the drugs of choice are combined glucocorticosteroids (GC), which in addition to GC contain an antimycotic and an antibiotic. Our practical experience shows the high effectiveness of the combination of beclomethasone dipropionate, gentamicin, and clotrimazole not only in cases of eczema complicated by secondary infection but also in patients with other infected chronic dermatoses. This article reviews these and other practical aspects and problems in the treatment of hand eczema, discusses the etiological factors that lead to the development of the disease, and presents current data from clinical recommendations and guidelines for the treatment of eczema.
- 1 January 2021
- Published by Russian Vrach, Publishing House Ltd. in Молекулярная медицина
- Vol. 19 (1) , 53-64
DNA Methylation Analysis of Lesional and Non-lesional Skin in Adult Patients with Atopic Dermatitis
Введение. Атопический дерматит (АтД) - это хроническое воспалительное заболевание, вызванное сложным взаимодействием как генетических, так и иммунных факторов, а так же факторов окружающей среды. В последнее время изучение эпигенетических изменений вносит новое понимание в этиологию АтД. Цель исследования. Изучение уровня метилирования ДНК в биопсиях пораженной и непораженной кожи пациентов с АтД. Методы. Выделение ДНК проводили набором QIAamp DNA Mini Kit (Qiagen, США). Бисульфитную конверсию выделенной ДНК проводили с использованием набора для метилирования ДНК EZ DNA Methylation Kit (Zymo Research, США). Уровни метилирования ДНК изучали путем гибридизации конвертированной ДНК с чипами BeadChip Infinium Human Methylation 450 (Illumina, США). Чипы сканировали при помощи HiScanSQ System (Illumina, США). Полученные изображения анализировали с помощью программнного обеспечения GenomeStudio® (версия 2011.1; модель метилирования версия 1.9.0, Illumina Inc.). Результаты. Были выявлены дифференциальные изменения в уровнях метилирования 26 генов из которых 9 были метилированы в промотерной области. Гиперметилированными были 11 генов, гипометилированными - 15 генов. Изменения уровня метилирования ДНК наблюдались для генов, белковые продукты которых участвуют в ряде биологических процессов, связанных с АтД: позитивная регуляция миграции фибробластов, распространение дендритных клеток и активация общего иммунитета. В области TSS200 в ткани пораженной АтД гипометилированым был только 1 ген - ALPK2, а гиперметилированы были два гена - CLNK и ARHGEF4. В области TSS1500 гипометилированными оказались 4 гена: MIR1178, VPS37C, GRIP2 и SLC47A2. Гены TCF12 и ZBTB20 были гиперметилированы. Заключение. Полученные результаты указывают на участие эпигенетической регуляции в развитии атопического процесса. Однако необходим дальнейший анализ дополнительных образцов кожи от новых пациентов для проверки и дальнейшего уточнения полученных...
- 1 January 2021
- Published by Russian Vrach, Publishing House Ltd. in Молекулярная медицина
- Vol. 19 (1) , 53-64
DNA Methylation Analysis of Lesional and Non-lesional Skin in Adult Patients with Atopic Dermatitis
Введение. Атопический дерматит (АтД) - это хроническое воспалительное заболевание, вызванное сложным взаимодействием как генетических, так и иммунных факторов, а так же факторов окружающей среды. В последнее время изучение эпигенетических изменений вносит новое понимание в этиологию АтД. Цель исследования. Изучение уровня метилирования ДНК в биопсиях пораженной и непораженной кожи пациентов с АтД. Методы. Выделение ДНК проводили набором QIAamp DNA Mini Kit (Qiagen, США). Бисульфитную конверсию выделенной ДНК проводили с использованием набора для метилирования ДНК EZ DNA Methylation Kit (Zymo Research, США). Уровни метилирования ДНК изучали путем гибридизации конвертированной ДНК с чипами BeadChip Infinium Human Methylation 450 (Illumina, США). Чипы сканировали при помощи HiScanSQ System (Illumina, США). Полученные изображения анализировали с помощью программнного обеспечения GenomeStudio® (версия 2011.1; модель метилирования версия 1.9.0, Illumina Inc.). Результаты. Были выявлены дифференциальные изменения в уровнях метилирования 26 генов из которых 9 были метилированы в промотерной области. Гиперметилированными были 11 генов, гипометилированными - 15 генов. Изменения уровня метилирования ДНК наблюдались для генов, белковые продукты которых участвуют в ряде биологических процессов, связанных с АтД: позитивная регуляция миграции фибробластов, распространение дендритных клеток и активация общего иммунитета. В области TSS200 в ткани пораженной АтД гипометилированым был только 1 ген - ALPK2, а гиперметилированы были два гена - CLNK и ARHGEF4. В области TSS1500 гипометилированными оказались 4 гена: MIR1178, VPS37C, GRIP2 и SLC47A2. Гены TCF12 и ZBTB20 были гиперметилированы. Заключение. Полученные результаты указывают на участие эпигенетической регуляции в развитии атопического процесса. Однако необходим дальнейший анализ дополнительных образцов кожи от новых пациентов для проверки и дальнейшего уточнения полученных...